Medical Device Investing Bausch Health Companies Inc. Will Release Fourth-Quarter And Full-Year 2020 Financial Results On February 24
Pharmaceutical Investing Pfizer Shares Co-Primary Endpoint Results from Post-Marketing Required Safety Study of XELJANZ® in Subjects with Rheumatoid Arthritis
Pharmaceutical Investing Merck Presents Interim Findings from Phase 2a Clinical Trial Evaluating Investigational Once-Monthly Oral Islatravir for the Prevention of HIV-1 Infection at HIVR4P 2021
Psychedelics Investing Seelos Therapeutics Announces Pricing of $31.25 Million Public Offering of Common Stock
Medical Device Investing Abbott's Panbio Rapid Antigen Test Receives CE Mark for Asymptomatic Screening and Self-Administered Sample Collection with Nasal Swab
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain MetastasisÂ
